In the News
OraSure Technologies, Inc. announces that its Diversigen and CoreBiome subsidiaries have combined their microbiome service offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled
In this article we’re sharing results from the validation study scientists at Diversigen and DNA Genotek undertook to ensure Diversigen’s viral metagenomics capabilities could be
“The virome is comprised of endogenous retroviruses, eukaryotic viruses, and bacteriophages and is increasingly being recognized as an essential part of the human microbiome. The
“Inflammatory bowel diseases, which include Crohn’s disease and ulcerative colitis, affect several million individuals worldwide. Crohn’s disease and ulcerative colitis are complex diseases that are
Nature Communications publishes new research showing that Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection
Nature Communications publishes new research from Joseph Petrosino, PhD, Diversigen Founder and Chief Science Officer, and other leading researchers. Using multidisciplinary approaches, the research report shows that a complex interplay between human milk oligosaccharid[es (HMOs), milk microbiome, and infant gut microbiome impacts neonatal rotavirus infections.
Cleveland Clinic today announced the Top 10 Medical Innovations of 2017 at a multi-media presentation that climaxed the 2016 Medical Innovation Summit.
Topping the 11th annual list is the harnessing of the microbiome, the gut bacteria swarming in all of us. Recent discoveries have revealed the power of microbes to prevent, diagnose and treat disease. The healthcare industry will soon be pouring resources into addressing the potential for new therapies, diagnostics, probiotics and other products.